Sara Nik

Stock Analyst at HC Wainwright & Co.

(0.23)

# 433

Out of 5,182 analysts

7

Total ratings

28.57%

Success rate

-33.9%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Sara Nik

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	KTTA Pasithea Therapeutics	Reiterates: Buy	$3	$0.85	+252.94%	2	Apr 20, 2026
	MBRX Moleculin Biotech	Reiterates: Buy	$22	$2.48	+787.10%	4	Mar 24, 2026
	CRIS Curis	Reiterates: Buy	$17	$0.62	+2,656.16%	1	Mar 20, 2026

Pasithea Therapeutics

Apr 20, 2026

Reiterates: Buy

Price Target: $3

Current: $0.85

Upside: +252.94%

Moleculin Biotech

Mar 24, 2026

Reiterates: Buy

Price Target: $22

Current: $2.48

Upside: +787.10%

Curis

Mar 20, 2026

Reiterates: Buy

Price Target: $17

Current: $0.62

Upside: +2,656.16%